Determination of type 2 diabetes risk levels in individuals applying to family medicine
Objevtive: Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease and an important public health problem worldwide. T2DM is a progressive disease and can exist without symptoms for many years. Therefore, the risk of chronic complications and the burden of disease increase. The aim of this study was to determine the diabetes risk level of the individuals who applied to the family medicine outpatient clinic and to guide the high-risk patients for diagnosis and intervention.
Methods: This descriptive study was carried out with the participation of 171 people who applied to family medicine outpatient clinics. The questionnaire form developed by the researchers was applied face to face; height, weight and waist circumferences were measured. The questionnaire included questions about the socio-demographic characteristics, disease and health habits of the participants, as well as The Finnish Diabetes Risk Score (FINDRISC). The statistical significance level was accepted as p˂0.05.
Results: The median (25.p-75.p) age of participants is 41 (33-52) and 61.4% (n:105) of the subjects were female; the median body mass index (BMI) is 26,42 (23,83-31,14) kg/m2. The mean waist circumference of the women is 90,63±14,69 cm (mean±sd); and 99,53±12,81 cm for males. The median FINDRISC scores of all participants were 10 (6-13), 11 (6-13) in women and 8 (5-13) in men. According to the FINDRISC, %19.3 of the individuals had a high to very high, %22.2 had a moderate and %58.5 had a slightly elevated-low risk for diabetes. There were positive and statistically significant correlations between FINDRISC scores and age, BMI and waist circumference.
Conclusion: It is important that clinicians especially family physicians, who serve the adult population should screen patients who apply for any reason for diabetes in their daily practices. FINDRISK which can be implemented quickly and easily is a simple, inexpensive and clear scanning method.
- Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD) Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu-2017. http://temd.org.tr/admin/uploads/tbl_kilavuz/DI-YABET2017_web.pdf adresinden 23/11/2018 tarihinde indirilmiştir.
- Guariguata L, Whiting DR, Hambleton I, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103(2):137-49.
- International Diabetes Federation, Diabetes Atlas, 8th edition, 2017. http://www.diabetesatlas.org adresinden 23/11/2018 tarinde erişilmiştir.
- Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013;28(2):169–80.5. Centers for Disease Control and Prevention, National Diabetes Prevention Program, 2016. https://www.cdc.gov/diabetes/prevention/index.html adresinden 23/11/2018 tarinde erişilmiştir.6. International Diabetes Federation, IDF Clinical Practice Recommendations for Managing Type 2 Diabetes in Primary Care 2017. https://www.idf.org/e-library/guidelines/128-idf-clinical-practice-recommendations-for-managing-type-2-diabetes-in-primary-care.ht ml adresinden 23/11/2018 tarinde erişilmiştir.7. Lindström J, Tuomilehto J. A practical tool to predict type 2 diabetes risk. Diabetes Care 2003;26(3):725-31.8. Demirağ HE. Tip-2 Diabetes Mellituslu Hastaların Birinci Derece Yakınlarında Diyabet Risk Değerlendirmesi. Aydın, Adnan Menderes Üniversitesi, 2016.9. Cosansu G, Celik S, Özcan S, Olgun N, Yıldırım N, Demir HG. Determining type 2 diabetes risk factors for the adults: A community based study from Turkey. Prim Care Diabetes 2018;12(5):409-15.10. Çevik AB, Karaaslan MM, Koçan S, et al. Prevalence and screening for risk factors of type 2 diabetes in Rize, Nourtheast Turkey: findings from a population-based study. Prim Care Diabetes 2016;10(1):10-8.11. Kutlu R, Sayın S, Koçak A. Tanı Almamış Tip 2 Diyabet İçin Bir Tarama Metodu Olarak Fin Diyabet Risk Anketi (FINDRISK) Uygulanabilir mi? Konuralp Tıp Dergisi 2016;8(3):158-66.12. Koçak HS, Selma Ö, Handan Z, Emine ÜS. Sınıf öğretmenlerinde tip 2 diyabet riski ve sağlıklı yaşam biçimi davranışlarının belirlenmesi. Turk J Public Health 2017;15(2):70-83.13. Makrilakis K, Liatis S, Grammatikou S, et al. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab 2011;37(2):144-51.14. Zhang L, Zhang Z, Zhang Y, Hu G, Chen L. Evaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999-2010. PLoS One 2014;9(5):e97865.15. Awad A, Alsaleh FM. 10-year risk estimation for type 2 diabetes mellitus and coronary heart disease in Kuwait: a cross-sectional population-based study. PLoS One 2015;10(1):e0116742.16. Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD) Obezite Tanı ve Tedavi Kılavuzu-2018. http://www.temd.org.tr/admin/uploads/tbl_gruplar/20180525144116-2018-05-25tbl_gruplar144108.pdf adresinden 23/11/2018 tarihinde indirilmiştir.17. Akman M, Sakarya S. Avrupa’da Birinci Basamak Sağlık Hizmetlerinin Değerlendirilmesi: QUALICOPC Projesi Türkiye Sonuçları. İstanbul, TAHEV Yayınları, 2017.